期刊文献+

罗格列酮对兔髂动脉球囊损伤术后脂联素表达及内膜增殖的影响 被引量:1

Effects of rosiglitazone on expression of adiponectin and intimal proliferation after balloon endothelial denudation of iliac artery in rabbits
下载PDF
导出
摘要 目的观察罗格列酮对兔髂动脉球囊内膜剥脱术后,脂联素表达水平及内膜增殖的影响,并探讨罗格列酮预防血管再狭窄的可能机制。方法将30只雄性新西兰大白兔随机分为3组,即正常对照组(给予普通饮食)、模型组(给予高脂饮食+球囊剥脱术)和罗格列酮组(给予高脂饮食+球囊剥脱术+罗格列酮)。分别于球囊损伤术后第1、4周,取血测定血脂、血糖;用ELISA法测定血浆脂联素的水平。取髂动脉标本进行病理形态学观察及弹力纤维染色。用免疫组化染色法测定增殖细胞核抗原(PCNA)的表达。结果成功建立了兔髂动脉血管内皮损伤模型。与模型组兔相比,罗格列酮组在术后第1、4周末,总胆固醇(TC)、三酰甘油(TG)和低密度脂蛋白-胆固醇(LDL-C)等指标均明显降低(P<0.01),HE及弹力纤维染色提示,内膜增殖程度显著减轻,PCNA的表达减少,血浆脂联素的水平明显升高(P<0.05或P<0.01)。以上变化在术后4周末更为显著。结论罗格列酮可有效抑制血管损伤后内膜的增殖,其机制可能与通过PPARγ途径增加脂联素的表达水平有关。 AIM : To study the effects of rosiglitazone on the expression of adiponectin and intimal proliferation after balloon endothelial denudation in rabbits and to explore the mechanism of rosiglitazone in preventing restenosis. METHODS: Thirty male New Zealand white rabbits were randomly divided into control group (normal diet), model group (hypercholesterol diet plus balloon endothelial denudation) and rosiglitazone group (balloon endothelial denudation plus hypercholesterol diet supplemented with rosiglitazone). Serum lipids and adiponectin levels were measured at 1 week and 4 weeks after balloon endothelial injury. Local iliac arteries were sectioned for the analysis of pathological morphology and were stained for PCNA immunohistochemistrical analysis. RESULTS: Hypercholesterolemia was successfully induced. After rosiglitazone intervention, significant difference was found in the levels of serum TC, TG and LDL-C between model and rosiglitazone groups ( P 〈 0. 01 ). Compared with those in the model group, expression of PCNA in rosiglitazone group was significantly lowered and expression of adiponectin significantly increased (P 〈 0.05 ). These changes were more significant by the end of the 4th week after balloon endothelial denudation. CONCLUSION: Rosiglitazone efficiently inhibits intimal proliferation during restenosis after balloon injury, which may be related to the increasing expression of adiponectin.
出处 《心脏杂志》 CAS 2009年第4期462-466,共5页 Chinese Heart Journal
关键词 罗格列酮 过氧化物酶体增殖物激活受体Γ 脂联素 rosiglitazone peroxisome proliferator-activated receptor rabbit adiponectin
  • 相关文献

参考文献2

二级参考文献9

  • 1Durand E, Mallat Z, Addad F, et al . Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model[J]. J Am Coil Cardiol, 2002, 39(10) :1680 - 1685.
  • 2Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury [J]. Circ Res, 1993, 73(5) :792 -796.
  • 3Law RE, Meehan WP, Xi XP, et al . Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia [ J ]. J Clin Invest, 1996, 98(8) :1897 - 1905.
  • 4Goetze S, Xi XP, Kawano H, et al . PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells[J]. J Cardiovasc Pharm, 1999, 33(5) :798 -806.
  • 5Martin-Nizard F, Furman C, Delerive P, et al. Peroxisome proliferator-aetivated receptor activators inhibit oxidized low-density lipoprorein-induced endothelin-1 secretion in endothelial cells[J]. J Cardiovasc Pharmacol, 2002, 40 ( 6 ) :822 - 831.
  • 6Aizawa Y, Kawabe J, Hasebe N, et al. Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia[ J]. Circulation, 2001, 104(4 ) :455 - 560.
  • 7Redondo S, Ruiz E, Santos-Gallego CG, et al . Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-gamma, transforming growth factor-betal, and a Smad2-dependent mechanism [ J ]. Diabetes, 2005, 54 (3) :811 -817.
  • 8Takagi T, Yamamuro A, Tamita K, et al. Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotie lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study [ J ]. J Cardiol, 2005,45 (4) :139 - 147.
  • 9Paul CHAN,G Neil THOMAS,Brian TOMLINSON.Protective effects of trilinolein extracted from Panax notoginseng against cardiovascular disease[J].Acta Pharmacologica Sinica,2002,23(12):1157-1162. 被引量:46

共引文献10

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部